The EACPT is in a prime position to foster an
environment of exchange between research and policy within the field of
clinical pharmacology and therapeutics.
The European Association of Clinical Pharmacology and Therapeutics (EACPT) includes all
All medicines have risks of adverse effects, in
addition to their expected health benefits. The EACPT is very well placed to
provide up-to-date briefings and recommendations to policy makers on how
pharmacology can contribute positively to human health and wealth, through a
clear understanding of the clinical and cost benefit/risk ratio of medicines.
The EACPT is also in a strong position to advise on
the support needed for clinical pharmacology and therapeutics, and its
underpinning pharmacology, to ensure that established experts and emerging CPT professionals
in academia, the clinical domain, governance, industry and other roles can
continue to develop and use medicines effectively to meet current and new
challenges to human health.
For more
information on the Policy Community journal where this article was published please
visit www.paneuropeannetworks.com
